Cutera (NASDAQ:CUTR) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a research note published on Tuesday morning. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

Shares of Cutera stock opened at $0.04 on Tuesday. The firm has a market capitalization of $787,254.00, a P/E ratio of -0.01 and a beta of 1.36. The business has a fifty day simple moving average of $0.36 and a two-hundred day simple moving average of $0.48. Cutera has a 12 month low of $0.09 and a 12 month high of $3.00.

Hedge Funds Weigh In On Cutera

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP purchased a new position in Cutera, Inc. (NASDAQ:CUTR) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned about 0.82% of Cutera at the end of the most recent reporting period. Hedge funds and other institutional investors own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.